Evidence map›Paper›PMID 28604781›Full record

ArticlePLoS neglected tropical diseases2017

Deltamethrin resistance in Aedes aegypti results in treatment failure in Merida, Mexico.

Gonzalo M Vazquez-Prokopec, Anuar Medina-Barreiro, Azael Che-Mendoza, Felipe Dzul-Manzanilla, Fabian Correa-Morales, Guillermo Guillermo-May, Wilbert Bibiano-Marín, Valentín Uc-Puc, Eduardo Geded-Moreno, José Vadillo-Sánchez and 4 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Oviposition Deterrent and Larvicidal Activity ofTropical medicine and infectious disease · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gonzalo M Vazquez-ProkopecDepartment of Environmental Sciences, Emory University, Atlanta, Georgia, United States of America.ORCID http://orcid.org/0000-0002-0710-270X
Anuar Medina-BarreiroUnidad Colaborativa de Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Merida, Yucatan, Mexico.
Azael Che-MendozaCentro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE) Secretaría de Salud Mexico, Ciudad de Mexico, Mexico.
Felipe Dzul-ManzanillaCentro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE) Secretaría de Salud Mexico, Ciudad de Mexico, Mexico.
Fabian Correa-MoralesCentro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE) Secretaría de Salud Mexico, Ciudad de Mexico, Mexico.
Guillermo Guillermo-MayUnidad Colaborativa de Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Merida, Yucatan, Mexico.
Wilbert Bibiano-MarínUnidad Colaborativa de Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Merida, Yucatan, Mexico.
Valentín Uc-PucUnidad Colaborativa de Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Merida, Yucatan, Mexico.
Eduardo Geded-MorenoUnidad Colaborativa de Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Merida, Yucatan, Mexico.
José Vadillo-SánchezUnidad Colaborativa de Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Merida, Yucatan, Mexico.
Jorge Palacio-VargasSecretaria de Salud de Yucatan, Merida, Yucatan, Mexico.
Scott A RitchieCollege of Public Health, Medical and Veterinary Sciences, James Cook University, Cairns, Queensland, Australia.
Audrey LenhartCenters for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Pablo Manrique-SaideUnidad Colaborativa de Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Merida, Yucatan, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The operational impact of deltamethrin resistance on the efficacy of indoor insecticide applications to control Aedes aegypti was evaluated in Merida, Mexico. A randomized controlled trial quantified the efficacy of indoor residual spraying (IRS) against adult Ae. aegypti in houses treated with either deltamethrin (to which local Ae. aegypti expressed a high degree of resistance) or bendiocarb (to which local Ae. aegypti were fully susceptible) as compared to untreated control houses. All adult Ae. aegypti infestation indices during 3 months post-spraying were significantly lower in houses treated with bendiocarb compared to untreated houses (odds ratio <0.75; incidence rate ratio < 0.65) whereas no statistically significant difference was detected between the untreated and the deltamethrin-treated houses. On average, bendiocarb spraying reduced Ae. aegypti abundance by 60% during a 3-month period. Results demonstrate that vector control efficacy can be significantly compromised when the insecticide resistance status of Ae. aegypti populations is not taken into consideration.

Indexed as

Insecticide ResistanceAedesAnimalsHousingInsecticidesMexicoMosquito ControlNitrilesPhenylcarbamatesPyrethrinsTime FactorsbendiocarbdecamethrinInsecticidesNitrilesPhenylcarbamatesPyrethrins

Identifiers

PMID28604781
PMCPMC5481028

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.